- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 4 granted · 36 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2097 | Marathoner Biosciences | — | — |
| 2098 | AINGEAL, LLC | — | — |
| 2099 | Manifold Capital Partners LP | — | $16M |
| 2100 | Aspen Neuroscience | — | — |
| 2101 | Citryll | — | — |
| 2102 | Autolus Therapeutics | — | — |
| 2103 | INVENUX, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods Of Differentiating Neural Cells And Related Compositions And Methods Of Usegranted
- Methods Of Differentiating Neural Cells And Related Compositions And Methods Of Useapplication
- Methods Of Differentiating Neural Cells And Related Compositions And Methods Of Useapplication
- Methods Of Predicting Dopamine Production Capability Of Differentiated Neuronal Cellsgranted
- Automated Cell Manufacturing Methods And Systemsapplication
- Methods For Differentiating Dopaminergic Neurons From Stem Cellsgranted
- Automated Methods For Differentiating Dopaminergic Neurons From Stem Cellsapplication
- Methods For Differentiating Dopaminergic Neurons From Stem Cellsapplication
- Gene Editing Of GBA1 In Stem Cells And Method Of Use Of Cells Differentiated Therefromapplication
- Methods Of Predicting Engraftment Capability Of Differentiated Neuronal Progenitor Cellsgranted
- Aav-based Modulation Of GBA1 And Related Compositions And Uses Thereofapplication
- Methods Of Differentiating Neural Cells And Predicting Engraftment Thereof And Related Compositionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.